Fortress BiotechFBIO
那斯達克 · USD
2.77
-0.16
(-5.46%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
Fortress BiotechFBIO
2.77
-0.16
(-5.46%)
財務數據
損益表
- 0.20
- 0.13
- 0.15
- 0.15
- 0.15
- 0.13
- 0.16
- 0.18
- 0.16
- 0.16
- -42.60
- -34.67
- 14.32
- -1.79
- 3.36
- -13.10
- 24.92
- 7.42
- -8.80
- -0.25
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 16,038 | 16,079 | 17,631 | 16,413 | 13,139 | 15,120 | 14,629 | 14,896 | 13,030 | 19,946 |
營業成本 | 6,218 | 5,440 | 5,755 | 4,939 | 4,790 | 4,680 | 6,914 | 7,355 | 6,816 | 6,015 |
營業毛利 | 9,820 | 10,639 | 11,876 | 11,474 | 8,349 | 10,440 | 7,715 | 7,541 | 6,214 | 13,931 |
營業費用 | 17,559 | 15,428 | 18,518 | 47,947 | - | 34,275 | 29,907 | - | - | - |
研發費用 | 540 | -367 | 208 | 8,122 | 3,938 | 9,688 | 9,446 | 12,656 | 24,839 | 14,045 |
推銷及管理費用 | 15,893 | 14,730 | 17,246 | 38,761 | 25,663 | 22,563 | 22,090 | 20,836 | 17,941 | 22,643 |
非經常性項目費用 | - | - | - | - | - | 1,043 | - | 2,649 | - | -3,143 |
其他營業費用 | 1,126 | 1,065 | 1,064 | 1,064 | 1,065 | 981 | -1,629 | -814 | - | - |
營業利益 | -7,739 | -4,789 | -6,642 | -36,473 | -22,317 | -23,835 | -22,192 | -27,786 | -36,566 | -19,614 |
其他收入及費用 | 153,401 | 617 | 18,406 | 27,338 | 431 | 450 | 1,683 | 1,085 | 145 | -6,931 |
利息費用 | 3,368 | 2,041 | 2,741 | 2,519 | 2,805 | 2,594 | 6,209 | 2,122 | 2,602 | 2,060 |
稅前純益 | 142,294 | -6,213 | 9,023 | -11,654 | -24,691 | -25,979 | -26,718 | -28,823 | -39,023 | -28,605 |
所得稅 | 5,132 | -816 | 196 | - | - | 336 | -24 | - | - | 379 |
稅後純益 | 110,373 | -3,937 | 5,850 | 15,486 | -10,584 | -6,765 | -12,867 | -10,948 | -15,417 | -9,279 |
基本每股稅後盈餘(元) | 3.44 | -0.22 | 0.13 | 0.50 | -0.48 | -0.16 | -0.76 | -0.73 | -1.04 | - |
稀釋每股稅後盈餘(元) | 2.82 | -0.21 | 0.12 | 0.50 | -0.48 | -0.26 | -0.67 | -0.72 | -1.04 | -0.53 |
基本平均股數(千股) | 31540.00 | 31034.00 | 27244.00 | 26879.00 | 26450.00 | 27973.00 | 19697.00 | 18316.00 | 17151.00 | - |
稀釋平均股數(千股) | 38412.00 | 22233.00 | 33100.00 | 29824.00 | 26450.00 | 27973.00 | 19697.00 | 18316.00 | 17151.00 | - |
還原基本每股稅後盈餘(元) | 3.44 | -0.22 | 0.13 | 0.50 | -0.48 | -0.16 | -0.76 | -0.73 | -1.04 | - |
還原稀釋每股稅後盈餘(元) | 2.82 | -0.21 | 0.12 | 0.50 | -0.48 | -0.26 | -0.67 | -0.72 | -1.04 | -0.53 |
還原基本平均股數(千股) | 31,540 | 31,034 | 27,244 | 26,879 | 26,450 | 27,973 | 19,697 | 18,316 | 17,151 | - |
還原稀釋平均股數(千股) | 38,412 | 22,233 | 33,100 | 29,824 | 26,450 | 27,973 | 19,697 | 18,316 | 17,151 | - |
EBITDA(千元) | 121,547 | -1,216 | 10,263 | 19,612 | -6,293 | -2,410 | -5,336 | -7,661 | -10,970 | -5,070 |